These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7119300)

  • 1. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.
    Ferry JJ; Horvath AM; Bekersky I; Heath EC; Ryan CF; Colburn WA
    J Clin Pharmacol; 1988 Jan; 28(1):81-7. PubMed ID: 3350994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone per os is likely to have limited efficacy in horses.
    Peroni DL; Stanley S; Kollias-Baker C; Robinson NE
    Equine Vet J; 2002 May; 34(3):283-7. PubMed ID: 12108748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food on the bioavailability of prednisone.
    Tembo AV; Sakmar E; Hallmark MR; Weidler DJ; Wagner JG
    J Clin Pharmacol; 1976; 16(11-12):620-4. PubMed ID: 791973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo availability of commercial prednisone tablets.
    Sullivan TJ; Sakmar E; Albert KS; Blair DC; Wagner JG
    J Pharm Sci; 1975 Oct; 64(10):1723-5. PubMed ID: 1102660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute and relative bioavailability of oral acetaminophen preparations.
    Ameer B; Divoll M; Abernethy DR; Greenblatt DJ; Shargel L
    J Pharm Sci; 1983 Aug; 72(8):955-8. PubMed ID: 6688635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and pharmacokinetics of prednisone in humans.
    Disanto AR; Desante KA
    J Pharm Sci; 1975 Jan; 64(1):109-12. PubMed ID: 1133681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone.
    Uribe M; Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1976 Aug; 71(2):362-4. PubMed ID: 939399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone bioavailability in the dog.
    Tse FL; Welling PG
    J Pharm Sci; 1977 Dec; 66(12):1751-4. PubMed ID: 925942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.